Kinase Inhibitors: Global Markets

Published - Jun 2012| Analyst - Shalini Shahani Dewan| Code - BIO053C
Market Research Report Single User License: $3325

Report Highlights

The global kinase inhibitors market reached $28.1 billion in 2010 and nearly $29.1 billion in 2011. The market is expected to reach $40.2 billion by 2016, a compound annual growth rate (CAGR) of 6.7%.

Report Scope

The scope of this study encompasses kinase inhibitors in pharmaceutical and biotechnology markets.  BCC analyzes each market and its applications, regulatory environment, technology, market projections and market share.  Technological issues include the latest trends and developments.  The emerging market for enzyme inhibitors includes India, China, Japan, South Korea, Taiwan, Canada, Africa, Australia and New Zealand and others countries.

Analyst Credentials

A team of professionals in the biotechnology industry carried out this study.  The project manager is Shalini S. Dewan, who holds a master’s degree in pharmaceutical chemistry and has over 14 years of industry experience.  Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid.  Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S.  Some of her other reports with BCC are: Reagents for Chromatography; Spectroscopy − An Enduring Market; Advanced Drug Delivery Systems − Technologies and Global Markets; Orthopedic Drugs, Implants and Devices − Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry − The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging − Global Markets; Chiral Technology − Global Markets; Autacoids and Related Drugs − Technologies and Global Markets; Contraceptives − Technologies and Global Markets; Liver Disease Treatments − The Global Market; Hormone Replacement Therapies and Other Hormone Therapies − Global Markets; Cardiovascular Medicine − Diagnostics, Drugs and Devices; and Cancer Therapies − Technologies and Global Markets.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at(+1) 781-489-7301 or contact us at
Title/Chapter Name Pages Price
Full Report: Kinase Inhibitors: Global Markets 219 $3325
Chapter- 1: INTRODUCTION 3
Chapter- 2: SUMMARY 2 $250
Chapter- 3: OVERVIEW 11 $251
Chapter- 4: REGULATORY ASPECTS 6 $137
Chapter- 5: NEW DEVELOPMENTS 6 $137
Chapter- 6: GLOBAL MARKETS 35 $797
Chapter- 8: MARKETS IN EUROPE 34 $774
Chapter- 9: MARKETS IN ASIA 32 $729
Chapter- 10: EMERGING MARKETS 31 $706
Chapter- 11: PATENT ANALYSIS 9 $205
Chapter- 12: CURRENT STATUS 4 $91
Chapter- 13: COMPANY PROFILES 10 $228
Chapter- 14: ABBREVIATIONS 2 $46
List of Tables
List of Figures
Download Table of Contents
Share This Report